• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

by Miriam Bergeret, MSc | May 3, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.

This content is for Paid Members only.
Login Register
New Partnership Aims to Improve Genomic Variant Interpretation

New Partnership Aims to Improve Genomic Variant Interpretation

by Rachel Muenz | Jun 8, 2022 | Articles, News, Open Content

Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.

Illumina and Precision Health Team Up for Population Study

Illumina and Precision Health Team Up for Population Study

by Rachel Muenz | Jun 1, 2022 | Articles, News, Open Content

Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.

Singleron Extends Reach outside of China with Acquisition of Proteona

Singleron Extends Reach outside of China with Acquisition of Proteona

by Rachel Muenz | Mar 14, 2022 | Articles, News, Open Content

Last week, Chinese genomics company Singleron Biotechnologies, which develops single-cell multi-omics platform technologies and helps translate them to the clinic, announced it had acquired Proteona Pte. Ltd. Based in Singapore, Proteona is also focused on the...
Element and Jumpcode Team Up to Boost Many Genomic Applications

Element and Jumpcode Team Up to Boost Many Genomic Applications

by Jumpcode Genomics | Feb 24, 2022 | Articles, News, Open Content

SAN DIEGO, CA — Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode’s CRISPRclean technology on Element’s AVITI System. The...
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com